October 03, 2018
Rose
Memorial Sloan Kettering Cancer Center President, Dr. Craig Thompson, announced that he will resign from the boards of Merck and Charles River Laboratories. Merck is the maker of the blockbuster cancer treatment Keytruda. Memorial Sloan Kettering Cancer Center has been thrust under the microscope recently over controversy involving top officials' financial conflicts of interest.
from Kaiser Health News https://ift.tt/2y9Z43a
October 03, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Viewpoints: Lessons On Ways The Spending Bill Seriously Undermines The Health Law; Public Health At Risk By Government’s About-Face on Dangerous Pesticide- Why Is This Software Engineer In The Operating Room?: He Might Be Feeling Woosy, But His Technology Could Save People’s Lives
- State Highlights: Doctors Roll Out Patients Colorful Artwork To Humanize Waiting Room In New York City; Improper Dental Tool Cleaning Might Have Exposed Patients To HIV In Tennessee
- Meth Is Far More Potent Than It Ever Was Before But States Can’t Use Opioid Funds To Fight The Rising Crisis
- Fed Up With Poor Health Outcomes, Navajo Nation Aims To Take Medicaid Coverage Into Its Own Hands
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment